{"id":"NCT02135029","sponsor":"Pfizer","briefTitle":"Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins","officialTitle":"A Phase 3, Double-blind, Double-dummy, Randomized, Placebo And Active Controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Dyslipidemia Who Are Intolerant To Statins","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06","primaryCompletion":"2015-11","completion":"2015-11","firstPosted":"2014-05-09","resultsPosted":"2017-12-14","lastUpdate":"2017-12-14"},"enrollment":184,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"Bococizumab (PF-04950615;RN316)","otherNames":[]},{"type":"DRUG","name":"Atorvastatin","otherNames":[]},{"type":"OTHER","name":"Placebo for Bococizumab (PF-04950615;RN316)","otherNames":[]},{"type":"OTHER","name":"Placebo for atorvastatin","otherNames":[]}],"arms":[{"label":"Bococizumab (PF-04950615;RN316)","type":"EXPERIMENTAL"},{"label":"Atorvastatin","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a multicenter, double blinded, active and placebo controlled randomized clinical trial to demonstrate a superior lipid lowering effect of Bococizumab (PF-04950615; RN316) compared to placebo in subjects who are statin intolerant.","primaryOutcome":{"measure":"Percent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo","deltaMin":2.4,"sd":12.86},{"arm":"PF-04950615 150 Milligram (mg) + Placebo","deltaMin":-52,"sd":22.75},{"arm":"Atorvastatin 40 mg + Placebo","deltaMin":-32.6,"sd":20.98}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":40,"countries":["United States","Canada"]},"refs":{"pmids":["37994400","28304227"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1481030&StudyName=Randomized%20Clinical%20Trial%20of%20RN316%20%28PF-04950615%29%20in%20Subjects%20who%20are%20Intolerant%20to%20Statins"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":73},"commonTop":["Myalgia","Muscle spasms","Injection site reaction","Fatigue","Arthralgia"]}}